Similar articles

• Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis.

  Scherer LC, Sperhacke RD, Ruffino-Netto A, Rossetti ML, Vater C, Klatser P, Kritski AL. Scherer LC, et al. BMC Infect Dis. 2009 Dec 31;9:216. doi: 10.1186/1471-2334-9-216. BMC Infect Dis. 2009. PMID: 20043842 Free PMC article.
• An alternative approach to the management dilemma of the mildly dyskaryotic smear based on audit of outcome.

  Ifaturoti O, Lockwood S, Etheridge M, Ong PS, Rashid F, Jones MH. Ifaturoti O, et al. Cytopathology. 2000 Aug;11(4):268-74. doi: 10.1046/j.1365-2303.2000.00252.x. Cytopathology. 2000. PMID: 10983727
• API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.

  API Consensus Expert Committee. API Consensus Expert Committee. J Assoc Physicians India. 2006 Mar;54:219-34. J Assoc Physicians India. 2006. PMID: 16800350
• Increased uptake of cervical screening by women with HIV infection in Auckland regardless of ethnicity, requirement for an interpreter or level of education.

  Lowe M, Handy R, Ingram J, Nisbet M, Ritchie S, Thomas M, Briggs S. Lowe M, et al. N Z Med J. 2016 Jul 15;129(1438):22-31. N Z Med J. 2016. PMID: 27447132
• GenoType^® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs.

  Theron G, Peter J, Richardson M, Warren R, Dheda K, Steingart KR. Theron G, et al. Cochrane Database Syst Rev. 2016 Sep 8;9(9):CD010705. doi: 10.1002/14651858.CD010705.pub3. Cochrane Database Syst Rev. 2016. PMID: 27605387 Free PMC article. Review.